These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23256987)

  • 21. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia.
    Fenton WS; McGlashan TH
    Am J Psychiatry; 1994 Mar; 151(3):351-6. PubMed ID: 7906493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurological soft signs in early onset schizophrenia].
    Bourgou Gaha S; Halayem Dhouib S; Amado I; Bouden A
    Encephale; 2015 Jun; 41(3):209-14. PubMed ID: 24854724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A five-year followup study of deficit and nondeficit schizophrenia.
    Tek C; Kirkpatrick B; Buchanan RW
    Schizophr Res; 2001 Apr; 49(3):253-60. PubMed ID: 11356586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysfunctional attitudes and expectancies in deficit syndrome schizophrenia.
    Beck AT; Grant PM; Huh GA; Perivoliotis D; Chang NA
    Schizophr Bull; 2013 Jan; 39(1):43-51. PubMed ID: 21622849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study.
    Strauss GP; Harrow M; Grossman LS; Rosen C
    Schizophr Bull; 2010 Jul; 36(4):788-99. PubMed ID: 19095758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations.
    Mechri A; Bourdel MC; Slama H; Gourion D; Gaha L; Krebs MO
    Eur Arch Psychiatry Clin Neurosci; 2009 Jun; 259(4):218-26. PubMed ID: 19224114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of premorbid functioning during childhood in patients with deficit vs. non-deficit schizophrenia and in their healthy siblings.
    Bucci P; Mucci A; Piegari G; Nobile M; Pini S; Rossi A; Vita A; Galderisi S; Maj M
    Schizophr Res; 2016 Jul; 174(1-3):172-176. PubMed ID: 26825584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological soft signs in familial and sporadic schizophrenia.
    Fountoulakis KN; Panagiotidis P; Kimiskidis V; Nimatoudis I; Gonda X
    Psychiatry Res; 2019 Feb; 272():222-229. PubMed ID: 30590276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.
    Chatterjee A; Chakos M; Koreen A; Geisler S; Sheitman B; Woerner M; Kane JM; Alvir J; Lieberman JA
    Am J Psychiatry; 1995 Dec; 152(12):1724-9. PubMed ID: 8526237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obstetric complications and neurological abnormalities in neuroleptic-naive psychotic patients.
    Peralta V; Cuesta MJ; Serrano JF
    Eur Arch Psychiatry Clin Neurosci; 2006 Oct; 256(7):407-13. PubMed ID: 16788770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological soft signs in first-episode schizophrenia: a follow-up study.
    Bachmann S; Bottmer C; Schröder J
    Am J Psychiatry; 2005 Dec; 162(12):2337-43. PubMed ID: 16330599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurological abnormalities in schizophrenic patients and their siblings.
    Ismail B; Cantor-Graae E; McNeil TF
    Am J Psychiatry; 1998 Jan; 155(1):84-9. PubMed ID: 9433343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of the diagnosis of deficit syndrome in schizophrenia.
    Amador XF; Kirkpatrick B; Buchanan RW; Carpenter WT; Marcinko L; Yale SA
    Am J Psychiatry; 1999 Apr; 156(4):637-9. PubMed ID: 10200748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurological signs and the heterogeneity of schizophrenia.
    Arango C; Kirkpatrick B; Buchanan RW
    Am J Psychiatry; 2000 Apr; 157(4):560-5. PubMed ID: 10739414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia.
    Horan WP; Blanchard JJ
    Schizophr Res; 2003 Dec; 65(2-3):125-37. PubMed ID: 14630305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Components of the smooth pursuit function in deficit and nondeficit schizophrenia.
    Hong LE; Avila MT; Adami H; Elliot A; Thaker GK
    Schizophr Res; 2003 Sep; 63(1-2):39-48. PubMed ID: 12892856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroimaging evidence for the deficit subtype of schizophrenia.
    Voineskos AN; Foussias G; Lerch J; Felsky D; Remington G; Rajji TK; Lobaugh N; Pollock BG; Mulsant BH
    JAMA Psychiatry; 2013 May; 70(5):472-80. PubMed ID: 23467781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insight controlled for cognition in deficit and nondeficit schizophrenia.
    Dantas CR; Barros BR; Fernandes PT; Li LM; Banzato CE
    Schizophr Res; 2011 May; 128(1-3):124-6. PubMed ID: 21353484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.